Abstract:Depression is highly prevalent (6% 1-year prevalence) and is the second leading cause of disability worldwide. Available treatment options for depression are far from optimal, with response rates only around 50%. This is most likely related to a heterogeneous clinical presentation of major depression disorder (MDD), suggesting different manifestations of underlying pathophysiological mechanisms. Poorer treatment outcomes to first-line antidepressants were reported in MDD patients endorsing an "atypical" symptom profile that is characterized by preserved reactivity in mood, increased appetite, hypersomnia, a heavy sensation in the limbs, and interpersonal rejection sensitivity. In recent years, evidence has emerged that immunometabolic biological dysregulation is an important underlying pathophysiological mechanism in depression, which maps more consistently to atypical features. In the last few years human microbial residents have emerged as a key influencing variable associated with immunometabolic dysregulations in depression. The microbiome plays a critical role in the training and development of key components of the host's innate and adaptive immune systems, while the immune system orchestrates the maintenance of key features of the host-microbe symbiosis. Moreover, by being a metabolically active ecosystem commensal microbes may have a huge impact on signaling pathways, involved in underlying mechanisms leading to atypical depressive symptoms. In this review, we discuss the interplay between the microbiome and immunometabolic imbalance in the context of atypical depressive symptoms. Although research in this field is in its infancy, targeting biological determinants in more homogeneous clinical presentations of MDD may offer new avenues for the development of novel therapeutic strategies for treatment-resistant depression. This article is part of the Special Issue on "Microbiome & the Brain: Mechanisms & Maladies".

Impacts of microbiota and its metabolites through gut-brain axis on pathophysiology of major depressive disorder

Gut Microbial Clues to Bipolar Disorder: State‐of‐the‐art Review of Current Findings and Future Directions

Gut microbiota and its metabolites in depression: from pathogenesis to treatment

Gut Microbiome Remodeling Induces Depressive-Like Behaviors Through A Pathway Mediated by the Host'S Metabolism

Gut Microbiota Metabolites in Major Depressive Disorder—Deep Insights into Their Pathophysiological Role and Potential Translational Applications

Research Progress on Mechanisms of Modulating Gut Microbiota to Improve Symptoms of Major Depressive Disorder

Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism

Gut Microbiota, Bacterial Translocation, and Interactions with Diet: Pathophysiological Links between Major Depressive Disorder and Non-Communicable Medical Comorbidities

Characteristics of gut microbiota and metabolic phenotype in patients with major depressive disorder based on multi-omics analysis

The role of microbiota in the pathogenesis of schizophrenia and major depressive disorder and the possibility of targeting microbiota as a treatment option

Depression-associated gut microbes, metabolites and clinical trials

Gut microbiota modulates neurotransmitter and gut-brain signaling

Potential role of gut microbiota in major depressive disorder: A review

Microbiome and immuno-metabolic dysregulation in patients with major depressive disorder with atypical clinical presentation

The Gut Microbiota and Major Depressive Disorder: Current Understanding and Novel Therapeutic Strategies

Gut microbiota-derived short-chain fatty acids and depression: deep insight into biological mechanisms and potential applications

Comparative metaproteomics analysis shows altered fecal microbiota signatures in patients with major depressive disorder.

Research progress on intestinal flora and depression

Current Understanding of Gut Microbiota in Mood Disorders: An Update of Human Studies

Mood and Microbes: a Comprehensive Review of Intestinal Microbiota’s Impact on Depression

Reviewing the role of gut microbiota in the pathogenesis of depression and exploring new therapeutic options